InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Lentini Renee, Autre. Director active across 1 company, notably ImmunoGen, Inc.. In total, 14 disclosures have been published. History available since 30 June 2021. The latest transaction was disclosed on 2 February 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations14 total
14,723 sharesCommon StockSEC:0001104659-24-014710:0
8,435 shares0Common StockSEC:0001415889-24-002870:0
467 shares@ US$16.012.4% of flowCommon StockSEC:0001415889-24-000378:0
15,000 shares0Common StockSEC:0001415889-23-016970:0
9,000 shares@ US$10.7932.5% of flowCommon StockSEC:0001415889-23-014916:0
11,500 shares@ US$3.0511.7% of flowCommon StockSEC:0001415889-23-013290:0
18,218 shares@ US$5.2531.4% of flowCommon StockSEC:0001415889-23-011880:0
3,195 shares@ US$4.054.3% of flowCommon StockSEC:0001415889-23-010824:0
1,351 shares@ US$3.921.8% of flowCommon StockSEC:0001415889-23-000101:0
2,509 shares@ US$3.8253.3% of flowCommon StockSEC:0001415889-22-007323:0
1,957 shares@ US$5.603.5% of flowCommon StockSEC:0001179110-22-000101
1,957 shares@ US$5.6027.6% of flowCommon StockSEC:0001179110-22-000101:0
1,683 shares@ US$5.5222.4% of flowCommon StockSEC:0001179110-21-007313:0
1,683 shares@ US$5.522.8% of flowCommon StockSEC:0001179110-21-007313
14 of 14 declarations
About Lentini Renee
Renee Lentini serves as Vice President of Finance and Principal Accounting Officer at ImmunoGen, Inc. In this role, she is responsible for overseeing the financial management and accounting operations of the company. Lentini plays a key role in developing financial strategies and ensuring compliance with accounting standards. Her expertise in finance is essential to support ImmunoGen's growth.
